- On 16 February, at Walter Reed National Military Medical Center, the President had a skin lesion removed from his chest as part of his comprehensive health assessment. This tissue was sent for traditional biopsy.
- As expected, the biopsy confirmed that the small lesion was basal cell carcinoma. All cancerous tissue was successfully removed. The area around the biopsy site was treated presumptively with electrodessication and curettage at the time of biopsy. No further treatment is required.
- Basal cell carcinoma lesions do not tend to "spread" or metastasize, as some more serious skin cancers such as melanoma or squamous cell carcinoma are known to do. They do, however, have the potential to increase in size, resulting in a more significant issue as well as increased challenges for surgical removal.
- The site of the biopsy has healed nicely and the President will continue dermatologic surveillance as part of his ongoing comprehensive healthcare.
A basil cell carcinoma is a common type of skin cancer.
Catching it early (especially because it is localized) means there's likely no threat to the president.
But this is Joe Biden we're talking about. Literally anything could end this man once and for all.
No one wants to open their news app and read that a "skin lesion [was] removed from [the president's] chest."